July 9, 2015 – InDex Pharmaceuticals today announced that Uli Hacksell and Jesper Wiklund have been appointed as new members of the Board of Directors. Professor Hacksell and Mr Wiklund together bring to InDex over 40 years of senior management experience from the life sciences industry in drug development, commercial operations, and business development.

A new addition to the crew includes Yangzhou Wang as senior vice president of global operations. ⇨ Cerecor CEO Uli Hacksell, who joined after getting bumped

11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member of the Board of Directors, effective today. The estimated Net Worth of Uli Hacksell is at least 61 千$ dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over 61,000$ and over the last 17 years Uli sold CERC stock worth over 0$.Cerecor Inc stock worth over 61,000$ and over the last 17 years Uli … 2 hours ago Uli Hacksell Ph.D. BOARD MEMBER SINCE 2017 Read Bio. Prof. Helena Danielson Ph.D.

Uli Hacksell is considered to be independent in relation to the company as well as its senior management and in relation to major shareholders. “Uli Hacksell has tremendous experience of scaling life science companies and is highly regarded for his broad knowledge based on his past leading positions at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. Aug 14 (Reuters) - Cerecor Inc * Cerecor Inc announces retirement of Dr. Uli Hacksell as president and chief executive officer * Cerecor Inc says John Kaiser, chief business officer of Cerecor The estimated Net Worth of Uli Hacksell is at least $59.6 millier dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0. Hans Gunnar Hacksell, född 20 augusti 1938 i Stockholm, död 20 mars 2015, var en svensk officer i Armén. [1 Biografi.

För närvarande har Uli Hacksell inga aktier i Synact Pharma.

Uli Hacksell. Styrelseledamot. More about Uli Hacksell. Uli Hacksell. Född: 1950. Titel: Ledamot sedan 2018. Utbildning: Apotekare och Farm dr. Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag. Som vd för ACADIA Pharmaceuticals 2000-2015 ledde Hacksell

Uli Hacksell, born 1950, is a trained pharmacist and holds a PhD from Uppsala University. Uli Hacksell has more than 25 years experience from senior positions in both large pharmaceutical and biotech companies as well as more than 10 years experience as CEO of publicly owned companies. Uli Hacksell Hacksell, född 1950, har under 30 år arbetat inom farmaceutisk industri och bioteknikbolag.

View phone numbers, addresses, public records, background check reports and possible arrest records for Uli Hacksell. Whitepages people search is the most trusted directory. Background Checks

He initially joined ACADIA as Executive Vice President of Drug Discovery. Uli Hacksell (R)-11-Hydroxyaporphine (2) and (R)-11-hydroxy-10-methylaporphine (3) were synthesized from natural morphine by using new, short, and efficient synthetic sequences. The dopaminergic About Dr. Uli Hacksell Dr. Uli Hacksell, since May 3, 2018, a board member of Medivir, has held senior positions in major pharmaceutical and biotech companies for over 25 years and has more than 10 years’ experience as the CEO of publicly owned companies. Uli Hacksell Ph.D. BOARD MEMBER SINCE 2017 Read Bio. Prof. Helena Danielson Ph.D. BOARD MEMBER SINCE 2006 Read Bio. Erik Walldén BOARD MEMBER SINCE 2017 Read Bio. Release Summary.

Beslut om riktlinjer för ersättning till ledande befattningshavare. Beslut om bemyndigande för styrelsen att besluta om emissioner. Stämmans avslutande. Förslag till beslut Michael Shalmi MD, MBA Chairman; Uli Alf Hacksell PhD Director; Aleksandar Biography. Peter Sjöstrand MD. Independent Director. Peter Sjöstrand is a Uli Alf Hacksell · Medivir AB (publ) University of Uppsala. Fredrik Öberg · Medivir AB (publ) · Marie Helena Levander · Medivir AB (publ) · Stig Lennart Hansson Disruptive Materials AB. Peter Jan Sture Ström · Active Biotech AB (publ) · Bernd Robert Seizinger, Karolinska Institutet.
Ryanair boeing 777

“Uli Hacksell has tremendous experience of scaling life science companies and is highly regarded for his broad knowledge based on his past leading positions at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. Aug 14 (Reuters) - Cerecor Inc * Cerecor Inc announces retirement of Dr. Uli Hacksell as president and chief executive officer * Cerecor Inc says John Kaiser, chief business officer of Cerecor The estimated Net Worth of Uli Hacksell is at least $59.6 millier dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0. Hans Gunnar Hacksell, född 20 augusti 1938 i Stockholm, död 20 mars 2015, var en svensk officer i Armén. [1 Biografi.

Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $83,600 and over the last 17 years Uli sold CERC stock worth over $0.
Swedbank medlemslån räkna

bmc lund restaurang
notch skin
leva på småskaligt jordbruk
svarta marknaden flashback
smarteyes.se kristianstad
maria lilja konstnär
jobba franska

Uli Alf Hacksell · Medivir AB (publ) University of Uppsala. Fredrik Öberg · Medivir AB (publ) · Marie Helena Levander · Medivir AB (publ) · Stig Lennart Hansson

https://biography.omicsonline.org/south-africa/university-of-pretoria/oleg-reva- 1999507 .org/south-africa/index-pharmaceuticals/prof-uli-hacksell-1764561

He initially joined ACADIA as Executive Vice President of Drug Discovery.

In his past career he was Chairman at Glionova AB, Uli är synnerligen kvalificerad att ta över ledarskapet och hans dokumenterade erfarenhet från klinisk utveckling blir en stor tillgång för Medivir, säger styrelseordförande Anna Malm Bernsten, i pressmeddelandet. Uli Hacksell är ett känt ansikte för många farmaceuter. Uli Hacksell har tidigare varit vd för forskningsbolaget Medivir och har under 90-talet innehaft seniora positioner vid Astra, numera Astra Zeneca. Han är för närvarande även styrelsemedlem i bland annat forskningsbolagen Active Biotech, Index Pharmaceuticals och Medivir. För närvarande har Uli Hacksell inga aktier i Synact Pharma. Uli Hacksell actualmente es Board Member de Active Biotech, Chairman of the Board de Adhera Therapeutics y Director de Medivir. En Medivir, ùs tiene Uli Hacksell colegas incluyendo a 10, Yilmaz Mahshid (CEO) Uli Hacksell Peter Luthersson Caisa Lycken Christina Mattsson Adam Sabir Maria Strömme Gunnar Svedberg Johan Wall Eva Åkesson Närvarande suppleanter: utan rösträtt Sven Widmalm Närvarande suppleanter: Med rösträtt Anders Malmberg utan rösträtt Fredrik Hultman ToveLeire Företrädare för de anställda: Stefan Djurström Marie Ols Prof Uli Hacksell disputerade och avancerade till professor i organisk kemi vid farma-ceutiska fakulteten i Uppsala (1988; har därefter innehaft ett flertal ledande positioner inom Astra-koncernen, bl a som forskningschef, slutligen som VD på Draco.